Transgenic alpha1-antitrypsin (TgAAT): Update

Phase I testing of nebulised TgAAT in 40 healthy volunteers showed

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE